News and Events
May 2, 2022
Strike Pharma, Uppsala University and KTH Royal Institute of Technology present at CIMT 2022
CD40 agonistic, bispecific antibody candidates developed using ADAC technology ensure T-cell activation
April 8, 2022
Strike Pharma and Uppsala University present at AACR 2022
New data demonstrates proof of concept for ADAC technology platform